Bristol-Myers Squibb Company (BRM)
XETR
Closed
Oct 8, 2026
Day's Range
52.6852 wk Range
36.60Overview - BRM - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
128.31B
P/E (Trailing)
‪13.90‬
PEG Ratio
‪0.09‬
Price / Sales (TTM)
‪2.24‬
Price / Book
‪5.57‬
EV / EBITDA
‪7.63‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.09%‬
Held by Institutions
‪84.84%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪56.00‬
200-Day Avg
‪51.33‬
Dividends
Payout Ratio
‪55.29%‬
Frequency
Quarterly
Market Cap - BRM - Bristol-Myers Squibb Company
Peers - BRM - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
Profile Summary - BRM - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company focused on discovering, developing, licensing, manufacturing, and commercializing medicines for serious diseases. Bristol-Myers Squibb Company’s portfolio spans oncology, hematology, immunology, cardiovascular disease, and neuroscience, with products…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
